Geneos Wealth Management Inc. Anavex Life Sciences Corp. Transaction History

Geneos Wealth Management Inc.

$2.77 Billion
Q4 2024

A detailed history of Geneos Wealth Management Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 53,775 shares of AVXL stock, worth $464,616. This represents 0.02% of its overall portfolio holdings.

Number of Shares

53,775

Previous 68,225 21.18%

Holding current value

$464,616

Previous $387,000 49.1%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$5.11 - $12.56 $73,839 - $181,492	-14,450 Reduced 21.18%	53,775 $577,000
Q3 2024 Nov 14, 2024	SELL	$4.11 - $7.04 $88,365 - $151,360	-21,500 Reduced 23.96%	68,225 $387,000
Q2 2024 Jul 23, 2024	BUY	$3.39 - $5.02 $51,951 - $76,931	15,325 Added 20.6%	89,725 $378,000
Q1 2024 May 03, 2024	BUY	$4.55 - $6.75 $30,940 - $45,900	6,800 Added 10.06%	74,400 $378,000
Q4 2023 Jan 26, 2024	BUY	$5.04 - $9.95 $128,520 - $253,724	25,500 Added 60.57%	67,600 $629,000
Q1 2023 Apr 25, 2023	BUY	$8.32 - $11.75 $16,640 - $23,500	2,000 Added 4.99%	42,100 $360,000
Q4 2022 Jan 30, 2023	BUY	$7.65 - $14.43 $50,490 - $95,238	6,600 Added 19.7%	40,100 $371,000
Q3 2022 Nov 14, 2022	SELL	$8.9 - $12.86 $47,170 - $68,158	-5,300 Reduced 13.66%	33,500 $345,000
Q2 2022 Jul 22, 2022	BUY	$7.31 - $12.84 $52,266 - $91,806	7,150 Added 22.59%	38,800 $388,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $89,608 - $162,748	9,200 Added 40.98%	31,650 $389,000
Q3 2021 Nov 09, 2021	BUY	$16.82 - $25.75 $15,979 - $24,462	950 Added 4.42%	22,450 $402,000
Q2 2021 Jul 08, 2021	SELL	$10.16 - $28.86 $40,640 - $115,440	-4,000 Reduced 15.69%	21,500 $528,000
Q1 2021 Jun 17, 2021	BUY	$5.17 - $16.13 $5,170 - $16,129	1,000 Added 4.08%	25,500 $308,000
Q4 2020 May 19, 2021	BUY	$4.01 - $7.58 $2,005 - $3,790	500 Added 2.08%	24,500 $366,000
Q3 2020 Sep 07, 2021	BUY	$3.8 - $5.0 $38,000 - $50,000	10,000 Added 71.43%	24,000 $92,000
Q3 2018 Sep 07, 2021	BUY	$2.23 - $3.82 $31,220 - $53,480	14,000 New	14,000 $38,000

Others Institutions Holding AVXL

# of Institutions

163

Shares Held

26.6M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Anavex Life Sciences Corp. Transaction History